Products Quality Lab Reports Knowledge Calculator FAQ 💬 Get in touch
PTD-DBM vial
Focus

PTD-DBM.

Available Variants
5 mg

Research area: Focus

🛡️
For research purposes only. Not intended for use in humans or animals.
Neuroscience research

About PTD-DBM

PTD-DBM is studied in the context of neuroscience and cognitive research. The PTD component mediates cell-membrane penetration; the DBM component competes with CXXC5 for the PDZ domain of Dishevelled (Dvl), relieving CXXC5-mediated suppression of Wnt/β-catenin signaling.

Research Application

Used in the published literature as a tool to study Wnt/β-catenin signaling in hair follicle neogenesis and wound healing (topical application in mouse models).

Important to know

Claims circulating online are often not backed by valid clinical data. Treat all information as a starting point for your own scientific research, not as usage guidance.

5 mg
Lyophilized powder
Focus
see lab reports →
A fusion peptide combining a cell-penetrating protein transduction domain (PTD) with a Dishevelled-binding motif (DBM) derived from the CXXC5 protein. The verifiable primary literature does not describe PTD-DBM in a neuroprotection context — it documents it as a Wnt/β-catenin-activating peptide for hair follicle regeneration.
Not an approved drug; a preclinical research peptide tested so far only in mouse models, with no published human studies.

Sequence and regulatory status data are based on publicly available sources and refer to the compound in general, not to a specific product.

Research Overview

Studies on neuroscience-related peptides are predominantly preclinical.

  • Lee SH, et al. J Invest Dermatol. 2017;137(11):2260–2269.

References without a PMID can be located via the respective publisher. This overview does not claim to be exhaustive.

Question about PTD-DBM?

We reply personally – via email or Telegram.

✉️ Email ✈️ Telegram
← Back to overview